GleamWall
中文EN

BCPC BALCHEM CORP

Chemicals & Allied Products · Nasdaq · SEC CIK 9326 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY9.4%
TTM net income YoY14.5%
TTM EPS YoY16.2%
Revenue 3-yr CAGR6.2%
Net income 3-yr CAGR18.3%

Margins

Gross margin36.5%
Operating margin20.7%
Net margin15.4%
FCF margin—
EBITDA margin25.1%

Returns

ROE13.0%
ROA10.2%
ROIC (approx.)14.3%
Asset turnover0.66x

Leverage & solvency

Liabilities / assets22.1%
Debt / equity0.00x
Current ratio2.47x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.31x
Accruals ratio-3.1%
Payout ratio18.0%
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$1.04B$953.68M$922.44M$942.36M$799.02M
Cost of revenue$666.53M$617.48M$620.38M$661.91M$555.85M
Gross profit$370.63M$336.21M$302.06M$280.45M$243.17M
R&D expense$18.51M$16.79M$15.05M$12.19M$13.52M
SG&A expense$67.42M$67.59M$53.42M$55.66M$41.73M
Operating income$209.33M$182.91M$159.19M$145.19M$127.50M
Pretax income$199.03M$166.45M$137.26M$133.75M$125.23M
Income tax$44.19M$37.98M$28.72M$28.38M$29.13M
Net income$154.84M$128.47M$108.54M$105.37M$96.10M
EBITDA$255.02M$230.88M$214.13M$197.03M$176.38M
EPS (basic)4.803.973.383.292.98
EPS (diluted)4.753.933.353.252.94
Dividends declared per share0.960.870.790.71—
Weighted avg. shares (diluted)32.60M32.72M32.45M32.39M32.67M
Banking
Net interest income——-$22.61M-$10.27M-$2.46M
Balance sheet
Cash & equivalents$74.57M$49.52M$64.45M$66.56M$103.24M
Receivables$143.60M$119.66M$125.28M$131.58M$117.41M
Inventory$131.45M$130.80M$109.52M$119.67M$91.06M
Current assets$365.61M$313.77M$314.24M$335.80M$322.23M
PP&E, net$306.65M$282.15M$276.04M$271.36M$237.52M
Goodwill$816.38M$780.03M$778.91M$769.51M$523.95M
Intangibles$132.99M$132.48M$191.21M$213.29M$94.67M
Total assets$1.69B$1.58B$1.60B$1.62B$1.20B
Current liabilities$176.38M$157.69M$148.49M$140.04M$143.80M
Total liabilities$428.84M$425.46M$543.23M$686.23M$322.31M
Shareholders' equity$1.26B$1.15B$1.05B$938.28M$877.01M
Shares outstanding32.06M32.53M32.25M32.15M32.29M
Cash flow statement
Operating cash flow$216.56M$182.00M$183.76M$138.54M$160.51M
Capital expenditure———$49.09M$36.14M
Free cash flow———$89.45M$124.37M
Investing cash flow-$43.89M-$59.74M-$34.81M-$416.01M-$35.30M
Financing cash flow-$152.81M-$133.81M-$153.32M$246.68M-$102.18M
Depreciation & amortization$45.69M$47.97M$54.94M$51.85M$48.88M
Stock-based compensation$18.06M$16.68M$16.05M$13.22M$10.80M
Dividends paid$28.29M$25.58M$22.87M$20.71M$18.72M
Share buybacks$107.64M$5.68M$4.47M$35.42M$35.24M

Free plan shows the latest 5 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-19 06:28.